Myriad Genetics (MYGN) News Today $9.71 -0.27 (-2.71%) As of 11:50 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Sei Investments Co. Acquires 174,770 Shares of Myriad Genetics, Inc. (NASDAQ:MYGN)Sei Investments Co. increased its holdings in shares of Myriad Genetics, Inc. (NASDAQ:MYGN - Free Report) by 7.4% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 2,526,761 shares of the company's stock after purchasinMarch 25 at 4:40 AM | marketbeat.comNatixis Advisors LLC Sells 110,685 Shares of Myriad Genetics, Inc. (NASDAQ:MYGN)Natixis Advisors LLC reduced its position in Myriad Genetics, Inc. (NASDAQ:MYGN - Free Report) by 34.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 209,328 shares of the company's stock after sMarch 24 at 3:42 AM | marketbeat.comCharles Schwab Investment Management Inc. Acquires 42,233 Shares of Myriad Genetics, Inc. (NASDAQ:MYGN)Charles Schwab Investment Management Inc. boosted its holdings in Myriad Genetics, Inc. (NASDAQ:MYGN - Free Report) by 3.9% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,125,535 shares of the company'sMarch 21, 2025 | marketbeat.com1 Small-Cap Stock on Our Watchlist and 2 to AvoidMarch 20, 2025 | uk.finance.yahoo.comAmundi Grows Stock Holdings in Myriad Genetics, Inc. (NASDAQ:MYGN)Amundi raised its stake in Myriad Genetics, Inc. (NASDAQ:MYGN - Free Report) by 175.1% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 43,978 shares of the company's stock after buying an additional 27,989 sharMarch 20, 2025 | marketbeat.comMyriad Genetics (MYGN): Buy, Sell, or Hold Post Q4 Earnings?March 17, 2025 | msn.comConnor Clark & Lunn Investment Management Ltd. Increases Stock Holdings in Myriad Genetics, Inc. (NASDAQ:MYGN)Connor Clark & Lunn Investment Management Ltd. increased its stake in shares of Myriad Genetics, Inc. (NASDAQ:MYGN - Free Report) by 377.6% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 549,456 shares of the company's stock after purchasingMarch 16, 2025 | marketbeat.comMyriad Genetics (NASDAQ:MYGN) Shares Gap Up - Should You Buy?Myriad Genetics (NASDAQ:MYGN) Shares Gap Up - Time to Buy?March 13, 2025 | marketbeat.comMyriad Genetics (NASDAQ:MYGN) Raised to Overweight at Piper SandlerPiper Sandler raised Myriad Genetics from a "neutral" rating to an "overweight" rating and lifted their target price for the stock from $11.50 to $12.50 in a research report on Wednesday.March 13, 2025 | marketbeat.comMyriad Genetics (NASDAQ:MYGN) Downgraded by StockNews.com to "Hold"StockNews.com downgraded Myriad Genetics from a "buy" rating to a "hold" rating in a research report on Thursday.March 13, 2025 | marketbeat.comMyriad Genetics upgraded to Overweight from Neutral at Piper SandlerMarch 12, 2025 | markets.businessinsider.comPiper Sandler Upgrades Myriad Genetics (MYGN)March 12, 2025 | msn.comWhy Are Myriad Genetics (MYGN) Shares Soaring TodayMarch 12, 2025 | msn.comMyriad Genetics upgraded at Piper Sandler on balanced risk reward setupMarch 12, 2025 | msn.comAnalyst Sees Bottom For Myriad Genetics Stock, Issues UpgradeMarch 12, 2025 | benzinga.comBuy Rating on Myriad Genetics: Strategic Changes and Growth Potential Amid ChallengesMarch 12, 2025 | tipranks.comMyriad Genetics price target lowered to $16 from $21 at Morgan StanleyMarch 11, 2025 | markets.businessinsider.comMyriad Genetics (NASDAQ:MYGN) Hits New 1-Year Low - Here's What HappenedMyriad Genetics (NASDAQ:MYGN) Hits New 1-Year Low - Should You Sell?March 11, 2025 | marketbeat.comEssex Investment Management Co. LLC Sells 119,132 Shares of Myriad Genetics, Inc. (NASDAQ:MYGN)Essex Investment Management Co. LLC decreased its holdings in Myriad Genetics, Inc. (NASDAQ:MYGN - Free Report) by 50.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 116,709 shares of the company's stMarch 10, 2025 | marketbeat.comMyriad Genetics (NASDAQ:MYGN) Updates FY 2025 Earnings GuidanceMyriad Genetics (NASDAQ:MYGN) updated its FY 2025 earnings guidance. The company provided EPS guidance of 0.070-0.110 for the period, compared to the consensus estimate of 0.060. The company also issued revenue guidance of $840.0 millionillion-$860.0 millionillion, compared to the consensus estimate of $863.0 millionillion.March 7, 2025 | marketbeat.comMyriad Genetics, Inc. (NASDAQ:MYGN) Receives Consensus Recommendation of "Hold" from AnalystsShares of Myriad Genetics, Inc. (NASDAQ:MYGN - Get Free Report) have earned an average rating of "Hold" from the fifteen research firms that are covering the firm, MarketBeat reports. Three investment analysts have rated the stock with a sell recommendation, seven have issued a hold recommendationMarch 7, 2025 | marketbeat.comAnalyst Expectations For Myriad Genetics's FutureMarch 5, 2025 | nasdaq.comPiper Sandler Has Lowered Expectations for Myriad Genetics (NASDAQ:MYGN) Stock PricePiper Sandler cut their price target on shares of Myriad Genetics from $14.00 to $11.50 and set a "neutral" rating for the company in a research report on Tuesday.March 5, 2025 | marketbeat.comUS$19.13: That's What Analysts Think Myriad Genetics, Inc. (NASDAQ:MYGN) Is Worth After Its Latest ResultsMarch 5, 2025 | finance.yahoo.comMyriad Genetics price target lowered to $11.50 from $14 at Piper SandlerMarch 4, 2025 | markets.businessinsider.comMyriad Genetics, Inc. (NASDAQ:MYGN) Shares Purchased by Fisher Asset Management LLCFisher Asset Management LLC increased its position in shares of Myriad Genetics, Inc. (NASDAQ:MYGN - Free Report) by 50.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 905,209 shares of the company's stock after acquiring an addMarch 4, 2025 | marketbeat.comAnalysts Offer Insights on Healthcare Companies: Myriad Genetics (MYGN) and Veeva Systems (VEEV)March 3, 2025 | markets.businessinsider.comMyriad Genetics price target lowered to $11 from $13 at BofAMarch 3, 2025 | markets.businessinsider.comMyriad Genetics (NASDAQ:MYGN) Price Target Lowered to $11.00 at Bank of AmericaBank of America dropped their price objective on Myriad Genetics from $13.00 to $11.00 and set an "underperform" rating for the company in a research report on Monday.March 3, 2025 | marketbeat.comMyriad Genetics Faces Financial Uncertainty Amid Potential Tax Law ChangesMarch 2, 2025 | tipranks.comQ1 EPS Estimates for Myriad Genetics Cut by Leerink PartnrsMyriad Genetics, Inc. (NASDAQ:MYGN - Free Report) - Equities researchers at Leerink Partnrs lowered their Q1 2025 EPS estimates for Myriad Genetics in a report issued on Tuesday, February 25th. Leerink Partnrs analyst P. Souda now expects that the company will post earnings of ($0.18) per share fMarch 1, 2025 | marketbeat.comMyriad Genetics (NASDAQ:MYGN) Lowered to Hold Rating by StockNews.comStockNews.com downgraded shares of Myriad Genetics from a "buy" rating to a "hold" rating in a report on Saturday.March 1, 2025 | marketbeat.comMyriad Genetics, Inc.: Myriad Genetics and Gabbi to Work Together to Increase Access to Hereditary Cancer Risk Assessment ToolsFebruary 28, 2025 | finanznachrichten.deLeerink Partnrs Predicts Myriad Genetics Q2 EarningsMyriad Genetics, Inc. (NASDAQ:MYGN - Free Report) - Stock analysts at Leerink Partnrs issued their Q2 2026 earnings per share (EPS) estimates for Myriad Genetics in a report issued on Tuesday, February 25th. Leerink Partnrs analyst P. Souda expects that the company will earn ($0.02) per share forFebruary 28, 2025 | marketbeat.comMyriad Genetics and Gabbi to Work Together to Increase Access to Hereditary Cancer Risk Assessment ToolsFebruary 28, 2025 | markets.businessinsider.comMyriad Genetics Inc (MYGN) Partners with Gabbi to Enhance Breast Cancer Risk AssessmentFebruary 27, 2025 | gurufocus.comMyriad Genetics price target lowered to $16 from $17 at TD CowenFebruary 26, 2025 | markets.businessinsider.comMyriad Genetics price target lowered to $19 from $27 at Raymond JamesFebruary 26, 2025 | markets.businessinsider.comPiper Sandler Keeps Their Hold Rating on Myriad Genetics (MYGN)February 26, 2025 | markets.businessinsider.comMyriad Genetics (MYGN) Receives a Buy from Craig-HallumFebruary 26, 2025 | markets.businessinsider.comMyriad Genetics, Inc. (MYGN): AI-Driven Precision Medicine for Prostate CancerFebruary 26, 2025 | msn.comWhy Myriad Genetics (MYGN) Shares Are Plunging TodayFebruary 26, 2025 | msn.comMyriad Genetics Faces Cost Restructuring As UnitedHealthcare Ends GeneSight Coverage, Appoints New CEOFebruary 25, 2025 | benzinga.comMyriad Genetics Faces Cost Restructuring As UnitedHealthcare Ends GeneSight Coverage, Appoints New CEOFebruary 25, 2025 | benzinga.comMyriad Genetics (NASDAQ:MYGN) Receives Outperform Rating from Raymond JamesRaymond James reissued an "outperform" rating and issued a $19.00 price target (down previously from $27.00) on shares of Myriad Genetics in a research report on Tuesday.February 25, 2025 | marketbeat.comMyriad Genetics (NASDAQ:MYGN) Price Target Lowered to $16.00 at UBS GroupUBS Group dropped their target price on Myriad Genetics from $18.00 to $16.00 and set a "neutral" rating for the company in a report on Tuesday.February 25, 2025 | marketbeat.comMyriad Genetics (NASDAQ:MYGN) Sets New 52-Week Low Following Weak EarningsMyriad Genetics (NASDAQ:MYGN) Sets New 1-Year Low Following Weak EarningsFebruary 25, 2025 | marketbeat.comMyriad Genetics (NASDAQ:MYGN) Releases Earnings Results, Misses Expectations By $0.12 EPSMyriad Genetics (NASDAQ:MYGN - Get Free Report) issued its earnings results on Monday. The company reported ($0.09) earnings per share for the quarter, missing the consensus estimate of $0.03 by ($0.12). The company had revenue of $210.60 million during the quarter, compared to analyst estimates of $210.35 million. Myriad Genetics had a negative return on equity of 4.51% and a negative net margin of 14.09%. During the same period in the prior year, the business earned ($0.12) earnings per share.February 25, 2025 | marketbeat.comCautious Outlook for Myriad Genetics Amid Leadership Transition and Revised Growth ProjectionsFebruary 25, 2025 | tipranks.comMyriad Genetics, Inc. (NASDAQ:MYGN) Q4 2024 Earnings Call TranscriptFebruary 25, 2025 | insidermonkey.com Remove Ads Get Myriad Genetics News Delivered to You Automatically Sign up to receive the latest news and ratings for MYGN and its competitors with MarketBeat's FREE daily newsletter. Email Address MYGN Media Mentions By Week MYGN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MYGN News Sentiment▼1.000.63▲Average Medical News Sentiment MYGN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MYGN Articles This Week▼47▲MYGN Articles Average Week Remove Ads Get Myriad Genetics News Delivered to You Automatically Sign up to receive the latest news and ratings for MYGN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies FOLD News LGND News DVAX News BCRX News MNKD News CLDX News NVAX News OPK News GERN News INVA News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MYGN) was last updated on 3/25/2025 by MarketBeat.com Staff From Our PartnersYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Myriad Genetics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Myriad Genetics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MYGN Stock Free MYGN Stock Alerts